USD 4.33
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 783 Thousand USD | -23.24% |
2022 | 1.02 Million USD | 353.33% |
2021 | 225 Thousand USD | -83.72% |
2020 | 1.38 Million USD | -3.0% |
2019 | 1.42 Million USD | 0.0% |
2018 | - USD | -100.0% |
2017 | 2.21 Million USD | 0.0% |
2016 | - USD | -100.0% |
2015 | 422.7 Thousand USD | 12.72% |
2014 | 375 Thousand USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 744 Thousand USD | -4.98% |
2024 Q2 | 698 Thousand USD | -6.18% |
2023 Q3 | 831 Thousand USD | -5.46% |
2023 Q1 | 974 Thousand USD | -4.51% |
2023 Q2 | 879 Thousand USD | -9.75% |
2023 Q4 | 783 Thousand USD | -5.78% |
2023 FY | 783 Thousand USD | -23.24% |
2022 Q3 | 1.06 Million USD | -5.08% |
2022 FY | 1.02 Million USD | 353.33% |
2022 Q1 | 1.15 Million USD | 414.67% |
2022 Q4 | 1.02 Million USD | -4.32% |
2022 Q2 | 1.12 Million USD | -3.02% |
2021 Q4 | 225 Thousand USD | -34.78% |
2021 Q3 | 345 Thousand USD | -69.33% |
2021 FY | 225 Thousand USD | -83.72% |
2021 Q2 | 1.12 Million USD | -10.29% |
2021 Q1 | 1.25 Million USD | -9.28% |
2020 Q3 | 2.21 Million USD | -3.4% |
2020 Q2 | 2.28 Million USD | 70.05% |
2020 Q4 | 1.38 Million USD | -37.5% |
2020 FY | 1.38 Million USD | -3.0% |
2020 Q1 | 1.34 Million USD | -5.51% |
2019 Q3 | 1.51 Million USD | -3.88% |
2019 Q4 | 1.42 Million USD | -6.12% |
2019 Q1 | 751.75 Thousand USD | 0.0% |
2019 Q2 | 1.57 Million USD | 110.08% |
2019 FY | 1.42 Million USD | 0.0% |
2018 Q3 | - USD | -100.0% |
2018 Q2 | 4.21 Million USD | 0.0% |
2018 FY | - USD | -100.0% |
2018 Q1 | 4.21 Million USD | 90.32% |
2018 Q4 | - USD | 0.0% |
2017 Q2 | 1.44 Million USD | -3.47% |
2017 Q4 | 2.21 Million USD | 36.22% |
2017 Q1 | 1.5 Million USD | 0.0% |
2017 FY | 2.21 Million USD | 0.0% |
2017 Q3 | 1.62 Million USD | 12.29% |
2016 FY | - USD | -100.0% |
2016 Q3 | - USD | 0.0% |
2016 Q2 | - USD | -100.0% |
2016 Q1 | 800 Thousand USD | 89.26% |
2016 Q4 | - USD | 0.0% |
2015 FY | 422.7 Thousand USD | 12.72% |
2015 Q4 | 422.7 Thousand USD | 0.0% |
2014 FY | 375 Thousand USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
electroCore, Inc. | 626 Thousand USD | -25.08% |
NeuroPace, Inc. | 72.39 Million USD | 98.918% |
Sight Sciences, Inc. | 35.41 Million USD | 97.789% |
TriSalus Life Sciences, Inc. | 1.59 Million USD | 50.909% |
SI-BONE, Inc. | 38.99 Million USD | 97.992% |
Anika Therapeutics, Inc. | 29.03 Million USD | 97.303% |
Accelerate Diagnostics, Inc. | 39.22 Million USD | 98.004% |
Cerus Corporation | 95.99 Million USD | 99.184% |
Axonics, Inc. | 27.61 Million USD | 97.165% |
908 Devices Inc. | 5.94 Million USD | 86.829% |
Treace Medical Concepts, Inc. | 70.3 Million USD | 98.886% |
TELA Bio, Inc. | 42.78 Million USD | 98.17% |
Venus Concept Inc. | 79.69 Million USD | 99.018% |
Tivic Health Systems, Inc. | 369 Thousand USD | -112.195% |
RxSight, Inc. | 3.01 Million USD | 74.004% |
LENSAR, Inc. | 2.3 Million USD | 66.089% |
Rapid Micro Biosystems, Inc. | 7.34 Million USD | 89.341% |
LivaNova PLC | 640.4 Million USD | 99.878% |
Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | 66.652% |
Lucid Diagnostics Inc. | 15.25 Million USD | 94.867% |
Alphatec Holdings, Inc. | 541.67 Million USD | 99.855% |
Apyx Medical Corporation | 38.5 Million USD | 97.966% |
Cutera, Inc. | 431.91 Million USD | 99.819% |
STRATA Skin Sciences, Inc. | 15.63 Million USD | 94.991% |
BioSig Technologies, Inc. | 452 Thousand USD | -73.23% |
Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 99.953% |
Bioventus Inc. | 409.47 Million USD | 99.809% |
Envoy Medical, Inc. | 404 Thousand USD | -93.812% |
Helius Medical Technologies, Inc. | 57 Thousand USD | -1273.684% |
Outset Medical, Inc. | 136.18 Million USD | 99.425% |
Nexalin Technology, Inc. | 4463.00 USD | -17444.253% |
IRIDEX Corporation | 2.74 Million USD | 71.486% |
PROCEPT BioRobotics Corporation | 79.2 Million USD | 99.011% |
IRadimed Corporation | 2.04 Million USD | 61.675% |
PAVmed Inc | 48.72 Million USD | 98.393% |
INVO Bioscience, Inc. | 8.68 Million USD | 90.983% |
Movano Inc. | 252 Thousand USD | -210.714% |
Cytek Biosciences, Inc. | 33.17 Million USD | 97.64% |
NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -324.62% |
Spectral AI, Inc. | 1.28 Million USD | 39.255% |
Viemed Healthcare, Inc. | 10.27 Million USD | 92.377% |
Varex Imaging Corporation | 469.5 Million USD | 99.833% |
Quipt Home Medical Corp. | 98.94 Million USD | 99.209% |
IceCure Medical Ltd | 599 Thousand USD | -30.718% |
Pulmonx Corporation | 41.42 Million USD | 98.11% |
Modular Medical, Inc. | 1.19 Million USD | 34.202% |
ReShape Lifesciences Inc. | 262 Thousand USD | -198.855% |
Insulet Corporation | 1.44 Billion USD | 99.946% |
Semler Scientific, Inc. | 70 Thousand USD | -1018.571% |
ClearPoint Neuro, Inc. | 13.94 Million USD | 94.383% |
Orthofix Medical Inc. | 134.19 Million USD | 99.417% |
InMode Ltd. | 9.01 Million USD | 91.316% |
Bruker Corporation | 1.37 Billion USD | 99.943% |
Surmodics, Inc. | 29.4 Million USD | 97.337% |
Cytosorbents Corporation | 18.31 Million USD | 95.724% |
iCAD, Inc. | 461 Thousand USD | -69.848% |
DexCom, Inc. | 2.59 Billion USD | 99.97% |
Align Technology, Inc. | 96.96 Million USD | 99.193% |
ZimVie Inc. | 521.92 Million USD | 99.85% |
Nexalin Technology, Inc. | 4463.00 USD | -17444.253% |
DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | 60.781% |
BrainsWay Ltd. | 471 Thousand USD | -66.242% |
Tandem Diabetes Care, Inc. | 415.66 Million USD | 99.812% |
Profound Medical Corp. | 7.9 Million USD | 90.089% |
enVVeno Medical Corporation | 1.4 Million USD | 44.151% |
Nuwellis, Inc. | 981 Thousand USD | 20.183% |
Nano-X Imaging Ltd. | 8.39 Million USD | 90.674% |
Aethlon Medical, Inc. | 940.31 Thousand USD | 16.73% |
Inogen, Inc. | 21.92 Million USD | 96.428% |
MaxCyte, Inc. | 18.74 Million USD | 95.822% |
iRhythm Technologies, Inc. | 129.82 Million USD | 99.397% |
OrthoPediatrics Corp. | 23.76 Million USD | 96.705% |
DIH Holding US, Inc. Warrants | 1.99 Million USD | 60.781% |
InspireMD, Inc. | 1.59 Million USD | 50.909% |
PAVmed Inc. | 48.72 Million USD | 98.393% |
Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -59.149% |
BIOLASE, Inc. | 17.91 Million USD | 95.628% |
Beyond Air, Inc. | 17.83 Million USD | 95.61% |
FONAR Corporation | 41.67 Million USD | 98.121% |
AxoGen, Inc. | 69.29 Million USD | 98.87% |
Vivani Medical, Inc. | 20.69 Million USD | 96.217% |
Tactile Systems Technology, Inc. | 50.37 Million USD | 98.446% |
Inari Medical, Inc. | 32.04 Million USD | 97.557% |
UFP Technologies, Inc. | 46.03 Million USD | 98.299% |
QT Imaging Holdings, Inc. | 3.07 Million USD | 74.504% |
Heart Test Laboratories, Inc. | 1.03 Million USD | 24.445% |
Co-Diagnostics, Inc. | 2.99 Million USD | 73.818% |
Tenon Medical, Inc. | 1.17 Million USD | 33.248% |
Autonomix Medical, Inc. Common Stock | 1 Million USD | 21.856% |
CVRx, Inc. | 30.61 Million USD | 97.442% |
AdaptHealth Corp. | 2.29 Billion USD | 99.966% |
Sintx Technologies, Inc. | 4.24 Million USD | 81.555% |
Vivos Therapeutics, Inc. | 1.99 Million USD | 60.752% |
NanoVibronix, Inc. | 5000.00 USD | -15560.0% |
Quanterix Corporation | 41.46 Million USD | 98.112% |
Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | 66.652% |
Pacific Biosciences of California, Inc. | 933.93 Million USD | 99.916% |
TransMedics Group, Inc. | 515.94 Million USD | 99.848% |
ReWalk Robotics Ltd. | 1.9 Million USD | 58.854% |
NeuroMetrix, Inc. | 240.87 Thousand USD | -225.064% |
Hyperfine, Inc. | 185 Thousand USD | -323.243% |
Establishment Labs Holdings Inc. | 192.22 Million USD | 99.593% |
Biomerica, Inc. | 785 Thousand USD | 0.255% |
Bone Biologics Corporation | - USD | -Infinity% |
AVITA Medical, Inc. | 449.48 Thousand USD | -74.2% |
Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -111.562% |
Silk Road Medical, Inc | 84.63 Million USD | 99.075% |